A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac disease and other immune-related conditions, the company announced Tuesday. The… Read More
Seattle biotech startup Nohla Therapeutics has an ambitious goal: Make umbilical stem cell transplants, currently a rare procedure, the new frontline treatment for leukemia. The company will have a new… Read More
Seattle startup Nohla Therapeutics has reeled in another $11 million to further develop its leukemia treatment. The spinout of Seattle’s Fred Hutchinson Cancer Research Center is developing a novel stem cell treatment for leukemia that… Read More
Seattle startup Nohla Therapeutics has raised another huge funding round as it moves its novel leukemia treatment closer to being approved by the FDA. The company added $45 million in… Read More
Amazon is continuing to bolster its health care game. The company recently hired Dr. Martin Levine, a longtime Seattle doctor and leader of Iora Health‘s Seattle area operations, according to… Read More
—Apple and Amazon are on a collision course in many industries, but the battle for tech talent looks to be heating up in the TV space. According to a report… Read More
Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million Series A round, bringing the startup’s total funding to date… Read More
Nohla Therapeutics just became the latest biotech startup to come out of the Fred Hutchinson Cancer Research Center. Like spinouts before it, Nohla is already well on its way to becoming one of Seattle’s rising… Read More